Published June 2003 | Version v1
Journal article

Neutron-rich radioisotope production in Australia

Creators

  • 1. Australian Nuclear Science and Technology Organisation, Menai, NSW (Australia). Radiopharmaceutical Division

Description

The author discusses Australia's Replacement Research Reactor (RRR) and the applications of the range of radioisotopes it will produce. The ANSTO's RRR will produce radioisotopes that have medical., industrial and environmental applications. Medicinal radioisotopes would provide the nuclear medicine physicians and oncologists with the necessary tool to non-invasively diagnose and cure diseases, ranging from cancer to infections. Industrial radioisotopes provide the industrial community with high technology tools to evaluate and assess the status of high reliability equipment with respect to safety and functionality in a non-destructive modality. The current commercial radioisotope sources include 60Co, 169Yb and 192Ir with source strengths limited by the HlFAR neutron flux and capacity. These sources are primarily used for industrial X ray moisture, level and thickness gauging. The RRR will allow expansion of the commercial source strengths and allow ANSTO to meet the growing commercial Australasian market for radioactive sources

Additional details

Publishing Information

Journal Title
Chemistry in Australia
Journal Volume
70
Journal Issue
5
Journal Page Range
p. 4-6
ISSN
0314-4240
CODEN
CHAUDY

Optional Information

Notes
2 figs., 1 tabs.